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22.7
The Cartilage Autograft Implantation System (CAIS) is being 
investigated in the US as a primary surgical treatment of articular 
cartilage lesion(s) located on the femur (medial and lateral 
condyles or trochlea).
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Purpose: The Cartilage Autograft Implantation System (CAIS) is 
being investigated as a primary surgical treatment of articular 
cartilage lesion(s) located on the femur (medial and lateral condyles 
or trochlea). CAIS involves preparation and delivery of a minced, 
autologous cartilage tissue-loaded scaffold the site of cartilage 
lesion(s)’ site within a single surgical procedure. This study is 
designed to assess safety and initial performance. 
Methods and Materials: Disposable instruments consisting of an 
arthroscopic device for harvesting and mincing cartilage tissue, 
dispersing unit, resorbable scaffold and staples, were developed 
and optimized. This multicenter, randomized, pilot clinical study (6 
sites) may enroll up to 30 subjects. Subjects are randomized in a 2:1 
schema (CAIS: microfracture (control) procedure). Subjects return for 
follow-up at 1 and 3 weeks, 2, 3, 6, 9 and 12 months post-operatively. 
Subjects are clinically evaluated and interviewed regarding the 
occurrence of adverse events and asked to complete questionnaires 
regarding disability, function, pain and quality of life. MRI are 
completed at baseline, 3 weeks, 6 and 12 months. 
Results: *OWJUSPTUVEJFTTIPXFG¾DJFOUIBSWFTUPGWJBCMFUJTTVFXJUI
potential outgrowth performance equivalent to previously published 
methods. Safety and performance of both clinical study arms will be 
reported through 6-months. 
Conclusions: The instrumentation enabled the successful preparation 
BOE¾YBUJPOPGBNJODFEBVUPMPHPVTDBSUJMBHFUJTTVFMPBEFEJNQMBOUJO
an intraoperative setting. CAIS device has demonstrated short-term 
safety in subjects treated to-date. Additional data must be analyzed 
regarding longer term safety and device performance.
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Mechanical stimulation and hyaluronic acid synergistically enhance 
remodeling and chondrogenic differentiation of three-dimensional 
collagen-based construct containing human synovium-derived stem cell
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Purpose: To evaluate the effect of mechanical stimulation and 
hyaluronic acid on the remodeling and chondrogenic differentiation 
of three-dimensional construct containing human synovium-derived 
stem cells. 
Methods and Materials: Human knee synovium was digested and 
librated cells were subcultured for 6 passages. These cells were used 
to build a three-dimensional construct with collagen gel and a collagen 
porous scaffold. Cyclic load (0.5Hz, 5 or 20 kPa, 1 hr/day) was applied 
to the construct with or without hyaluronic acid (1mg/ml). After 5 or 15 
days of culture, histological sections, mRNA expression levels and DNA 
amount of the constructs (n=3 each) were analyzed. Concentration of 
hyaluronic acid and glycosaminoglycan of cultured media were also 
measured. 
Results: Cyclic load stimulation with hyaluronic acid caused cell 
aggregation and extracellular matrix accumulation within the 
pericellular space in the three dimensional constructs. Real-time RT-
PCR revealed that cyclic loading of 20 kPa increased aggrecan and Sox 
9 mRNA expressions up to 270% and 150% respectively, whereas 5 
kPa loading had no effect. Hyaluronic acid synergistically increased 
these mRNA expressions up to 500% and 150% in 5 kPa and 700% and 
240% in 20 kPa respectively. Cyclic loading also upregulated MMP-
1, -3 mRNA expressions. CD44, TGF-b1 and HAS 2 mRNA expressions 
were upregulated by hyaluronic acid under cyclic load stimulation. 
Concentration of hyaluronic acid and glycosaminoglycan also increased 
by hyaluronic acid and mechanical stiulation. 
Conclusions: Mechanical stimulation and hyaluronic acid synergistically 
enhance remodeling and chondrogenic differentiation of three-
dimensional collagen-based construct containing human synovium-
derived stem cells. 
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The combination of dynamic compression and shear with rvBMP-2 
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Purpose: Both bioreactor conditions and gene therapy have shown 
to enhance chondrogenesis. The purpose of this study was to 
compare the effects of dynamic compression and shear, alone or in 
combination with retrovirally expressed bone morphogenetic protein 
2 (BMP-2), on chondrocytes in vitro. 
Methods and Materials: Primary bovine chondrocytes were either 
retrovirally transduced with BMP-2 or left untreated. Cells were 
seeded in 3-D polyurethane scaffolds (n=48) and further cultured 
VOEFSTUBUJDDPOEJUJPOTPSFYQPTFEUPEF¾OFEEZOBNJDDPNQSFTTJPO
BOETIFBSJOBKPJOUTQFDJ¾DCJPSFBDUPS0OFXFFLBGUFSTFFEJOHGPVS
groups were investigated: G1-uninfected, G2-BMP2-infected, G3-
VOJOGFDUFEMPBEBOE(#.1JOGFDUFEMPBEFBDIBUUISFFUJNF
points (d7, d21, d35). Outcome measurements included wet weight, 
DNA-content, glycosaminoglycan (GAG) medium release/scaffold 
content, collagen 1, 2, aggrecan, Sox 9 mRNA, histology and ELISA 
for BMP-2-transgene expression. Values given are normalized to G1 
at d35. 
Results: Wet weight/DNA-content were highest in G4/G2, while 
DNA-content declined over time. GAG release/scaffold content 
and GAG per DNA increased over time and was highest in G4/G3 
(p<0,05). Collagen 1 was lowest in G1/G4, collagen 2 was highest 
in G4/G2 (p<0,05), aggrecan was highest in G3/G4 (p<0,05), while 
Sox9 was highest in G4/G3 (p>0,05). Only collagen 2/aggrecan 
TIPXFE TJHOJ¾DBOU JODSFBTFT JO BMM HSPVQT PWFS UJNF $VNVMBUJPO
was highest in G4. Histology revealed highest cell density in G4/G2. 
BMP-2-transgene expression was stable through d35. 
Conclusions: When compared to control, in-vitro chondrogenesis 
JT NPTU FG¾DJFOU XIFO TJNVMUBOFPVT TUJNVMBUJPO XJUI EZOBNJD
compression and shear, combined with BMP-2, is applied.
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Purpose: We developed an ultrasonic measurement system to detect 
cartilage stiffness, surface roughness and thickness. The objective of this 
study was to evaluate the mechanical properties of the grafted cartilage 
(P), surrounding normal-like cartilage (N), the gap (G) and the donor (D) in 
second-look after mosaicplasty using our ultrasonic device. 
Methods and Materials: There were 22 patients 24 knees who had 
second-look arthroscopy after mosaicplasty, and we received their 
informed consent about this study. They were 8 men 14 women, 8 right 
knees 16 left ones. Their mean operative age in second-look was 47.4 year-
old. The mean period from mosaicplasty to second-look was 17.1 months. 
The number of measured areas was 73 in P, 34 in G and 42 in D. The ratio 
of the mechanical properties in P, G and D to the ones in N was calculated. 
Results: *OTUJGGOFTT1	
XBTTJHOJ¾DBOUMZMBSHFSUIBO(	

BOE%	
*OTVSGBDFSPVHIOFTT1	
XBTTJHOJ¾DBOUMZTNBMMFS
UIBO(	
BOE%	
*OUIJDLOFTTUIFSFXBTOPTJHOJ¾DBOU
*OUIFNFDIBOJDBMQSPQFSUJFTPG1UIFSFXBTTJHOJ¾DBOUEJGGFSFODFJOPOMZ
stiffness among the period from mosaicplasty to second-look. The ratio 
of stiffness in P was 58.4% in less than 6 months, 99.1% in from 11 to 16 
months and 204.7% in more than 22 months. 
Conclusions: At second-look, the grafted plugs had similar mechanical 
properties as normal after 1 year. However, the stiffness in P was larger 
than the stiffness in surrounding normal-like cartilage after 2 years.
